Development of a practice-based score to predict extended duration of proton beam therapy session in pediatric patients.

IF 2.5 3区 医学 Q2 ONCOLOGY
José M Fernández-de Miguel, Miguel Ángel García-Aroca, Ignacio Manrique Yera, Felipe A Calvo, María Aymerich de Francesci, Jose Manuel Álvarez Avello, Elena Panizo Morgado, Jorge M Núñez-Córdoba
{"title":"Development of a practice-based score to predict extended duration of proton beam therapy session in pediatric patients.","authors":"José M Fernández-de Miguel, Miguel Ángel García-Aroca, Ignacio Manrique Yera, Felipe A Calvo, María Aymerich de Francesci, Jose Manuel Álvarez Avello, Elena Panizo Morgado, Jorge M Núñez-Córdoba","doi":"10.1007/s12094-025-03972-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Due to the labor intensity demanded by proton beam therapy (PBT) in pediatric patients, information on operational procedures related to efficiency is crucial to optimize quality and safety. We aimed to identify patient factors that affect the duration of the pediatric PBT session and to develop an easy-to-use predictive score of extended duration.</p><p><strong>Methods/patients: </strong>This is an observational retrospective cohort study in an academic medical centre, between May 2020 and February 2024. Seventy seven ASA III pediatric patients treated with PBT were recruited.</p><p><strong>Results: </strong>The mean age was 4.8 years [standard deviation (SD): 2.1] and 52% were women. The mean duration of the PBT session was 50 min (SD: 17). Extended duration of the PBT session (> 45 min) occurred in 39 patients (51%). Five predictors of extended duration were selected for the final prediction model. In the multivariable model, an age > 45 months showed a near eightfold increased odds of extended duration [Odds ratio (OR): 7.76, 95% confidence interval (95% CI) 1.63-36.99, P = 0.010]. The OR (95% CI) for long-term venous access, no recurrent tumors, hydrocephalus, and craniospinal location were 5.91 (1.47 to 23.79), 3.81 (0.67 to 21.69), 3.79 (0.90 to 15.97), and 2.59 (0.69 to 9.76), respectively. This five-variable model was used to build a nomogram-based score with an area under the receiver operating characteristic curve of 0.84 (95% CI 0.76-0.93).</p><p><strong>Conclusions: </strong>A simple nomogram based on readily available pretreatment data has potential for planning pediatric PBT standard clinical expert practice.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-025-03972-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Due to the labor intensity demanded by proton beam therapy (PBT) in pediatric patients, information on operational procedures related to efficiency is crucial to optimize quality and safety. We aimed to identify patient factors that affect the duration of the pediatric PBT session and to develop an easy-to-use predictive score of extended duration.

Methods/patients: This is an observational retrospective cohort study in an academic medical centre, between May 2020 and February 2024. Seventy seven ASA III pediatric patients treated with PBT were recruited.

Results: The mean age was 4.8 years [standard deviation (SD): 2.1] and 52% were women. The mean duration of the PBT session was 50 min (SD: 17). Extended duration of the PBT session (> 45 min) occurred in 39 patients (51%). Five predictors of extended duration were selected for the final prediction model. In the multivariable model, an age > 45 months showed a near eightfold increased odds of extended duration [Odds ratio (OR): 7.76, 95% confidence interval (95% CI) 1.63-36.99, P = 0.010]. The OR (95% CI) for long-term venous access, no recurrent tumors, hydrocephalus, and craniospinal location were 5.91 (1.47 to 23.79), 3.81 (0.67 to 21.69), 3.79 (0.90 to 15.97), and 2.59 (0.69 to 9.76), respectively. This five-variable model was used to build a nomogram-based score with an area under the receiver operating characteristic curve of 0.84 (95% CI 0.76-0.93).

Conclusions: A simple nomogram based on readily available pretreatment data has potential for planning pediatric PBT standard clinical expert practice.

开发一种基于实践的评分来预测儿科患者质子束治疗持续时间的延长。
目的:由于儿科患者质子束治疗(PBT)所需的劳动强度,与效率相关的操作程序信息对优化质量和安全至关重要。我们的目的是确定影响儿童PBT持续时间的患者因素,并开发一个易于使用的延长持续时间的预测评分。方法/患者:这是一项观察性回顾性队列研究,于2020年5月至2024年2月在一家学术医疗中心进行。纳入77例接受PBT治疗的ASA III型儿科患者。结果:平均年龄为4.8岁[标准差(SD): 2.1], 52%为女性。PBT的平均持续时间为50分钟(SD: 17)。39例(51%)患者出现PBT疗程延长(45分钟)。选择五个延长持续时间的预测因子作为最终的预测模型。在多变量模型中,年龄在0 ~ 45个月时,延长病程的几率增加了近8倍[比值比(OR): 7.76, 95%可信区间(95% CI) 1.63 ~ 36.99, P = 0.010]。长期静脉通路、无复发肿瘤、脑积水和颅脊髓定位的OR (95% CI)分别为5.91(1.47 ~ 23.79)、3.81(0.67 ~ 21.69)、3.79(0.90 ~ 15.97)和2.59(0.69 ~ 9.76)。该五变量模型用于建立基于nomogram评分,其受试者工作特征曲线下面积为0.84 (95% CI 0.76-0.93)。结论:基于现成的预处理数据的简单nomogram有可能用于规划儿科PBT标准临床专家实践。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
2.90%
发文量
240
审稿时长
1 months
期刊介绍: Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信